{"id":"8634af1a-c8c3-41a6-aade-dfaf4586aa7a","arxiv_id":"2505.24057","paper_version":1,"verdict":"UNVERDICTED","confidence":"MODERATE","novelty_score":5.0,"correctness_risk":"high","formal_verification":"none","parameter_count":1,"one_line_summary":"A qualitative model in which aerosol deposition seeds early SARS-CoV-2 lung foci and inflammatory exudate fluid later drives diffuse viral spread.","lead":"This paper proposes that SARS-CoV-2 spreads through the lungs in two physical phases: first via inhaled and re-inhaled aerosols, then via inflammatory fluid that carries virus across lung tissue. It is a hypothesis paper with no new measurements, and its value depends on whether the proposed mechanisms can be tested.","discovery_kind":"unclear","skeptic_critique":{"model":"deepseek-v4-flash","headline":"Self-aerosol reseeding is the pivotal unquantified step: without an order-of-magnitude comparison of re-inhaled deposited virions versus local replication, the T_threshold shift is unsupported.","rationale":"The reader's weakest-assumption analysis correctly identifies the lack of a quantitative estimate for self-aerosol reseeding as the most load-bearing gap. I agree: the early aerosol-mediated phase and the subsequent switch to exudate-mediated transport both depend on this step being physically significant, yet the paper provides only temporal correlation and plausibility language. The concern is not that the hypothesis is outside consensus; it is internally underdetermined. The manuscript's own Sec. 6.2 explicitly concedes that the role and quantitative contribution of self-aerosol reseeding are unverified, which supports rather than undermines my reading. A concrete order-of-magnitude calculation using already-published emission and deposition data would settle whether the mechanism is even in the right regime; this is a feasible analysis test, not an unethical human challenge. Because the paper is framed as a hypothesis and its limitations are acknowledged, the reader's UNVERDICTED verdict remains appropriate, though the test I propose could later move it toward conditional acceptance or rejection depending on the outcome.","tokens_in":13814,"tokens_out":3575,"duration_ms":44194,"concrete_test":"Build an order-of-magnitude dose balance for phase 1 using published values: exhaled viral aerosol emission rate E (copies/min, e.g., ref [9]), a re-breathing fraction f_rebreathe estimated from room volume and ventilation, and fractional alveolar deposition f_dep from respiratory aerosol simulations [2]. Compute the daily self-re-inhaled deposited dose D = E × f_rebreathe × f_dep × 1440 min and compare it with the estimated daily local viral production from infected cells (infected cell count × burst size, roughly 10^3-10^5 virions/cell). If D is less than ~1% of local production, self-aerosol reseeding cannot materially accelerate early spread and the T_threshold mechanism loses quantitative support; if D is comparable to or larger than local production, the hypothesis becomes quantitatively plausible.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim (Sec. 4.3) is a dominance switch from aerosol-mediated to exudate-mediated intrapulmonary spread. The linchpin is Sec. 4.1.2: during days 1-5 after symptom onset, high oropharyngeal viral load causes the host to exhale and re-inhale enough virus-laden aerosol to seed new lung foci faster than local cell-to-cell spread. The paper itself flags this in Sec. 6.2 as a key unverified point, asking 'whether' and 'under what conditions' self-aerosol reseeding is significant. No quantitative estimate is provided: cited emission data [9] and deposition simulations [2] are used qualitatively, and the temporal alignment of oropharyngeal and lung viral load peaks (days 1-5 vs 5-10) is also compatible with ordinary centrifugal spread from a single focus or hematogenous seeding. Without a dose balance, the early aerosol-dominant phase and the location of T_threshold are unfalsifiable; P_aerosol(t) and P_exudate(t) are never defined, so the claimed dynamic equilibrium point has no operational meaning.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"This paper proposes a speculative, non-quantitative model for the intrapulmonary spread of SARS-CoV-2. The model posits two physical transport vehicles: aerosols (inhaled from the environment or self-generated and re-inhaled) dominate initial seeding and early expansion of infection, while inflammatory exudates later form a connected fluid network that transports virus over long distances, leading to diffuse CT lesions. A 'dynamic equilibrium point' T_threshold supposedly marks the temporal shift between these phases. The paper offers a narrative of clinical, viral-kinetic, and epidemiological observations as indirect support, together with conceptual designs for prospective and retrospective validation, and derives public health recommendations emphasizing ventilation and air filtration for both inter- and intra-host transmission.","tokens_in":14094,"tokens_out":3787,"duration_ms":43905,"significance":"If properly formalized and supported, the hypothesis would reframe intrapulmonary viral dissemination as a problem of physical transport media, with direct implications for non-pharmaceutical interventions inside the infected individual's microenvironment. The paper is honest about its status: it labels itself a hypothesis, explicitly lists unresolved points (notably the quantitative role of self-aerosol reseeding), and proposes concrete, testable experimental designs. These are genuine strengths. However, the central claim is currently a narrative rather than a model: the key quantities in Section 4.3 are undefined, and the supportive evidence in Section 5.2.1 largely reproduces the observations the model was built to explain. The significance of the framework therefore remains conditional on the authors replacing placeholders with an actual formal and quantitative formulation.","major_comments":[{"comment":"The central claim is the existence of a dynamic equilibrium point T_threshold where the dominant diffusion mechanism switches from aerosol-mediated to exudate-mediated spread, quantified by two unspecified functions P_aerosol(t) and P_exudate(t). These quantities are never defined: no equations, units, measurable proxies, or functional forms are given. As written, the 'equilibrium point' is a placeholder, not a model prediction. To make the hypothesis falsifiable, the authors must specify what P_aerosol and P_exudate measure (e.g., rate of new foci per day from aerosol deposition vs. rate of viral spread per day by exudate convection), how they depend on measurable variables (oropharyngeal viral load, exhaled aerosol concentration, minute ventilation, deposition fraction, exudate volume, airway geometry), and the equality or threshold condition that defines T_threshold. Without this, Section 4.3 cannot support the paper's stated goal of explaining the focal-to-diffuse transition.","section":"Section 4.3"},{"comment":"Self-aerosol reseeding is the pivotal mechanism for the early aerosol-dominant phase. The paper asserts that during the 1–5 day window of high oropharyngeal viral load, re-inhaled self-aerosols drive the expansion of lung infection faster than local cell-to-cell spread, yet it provides no quantitative estimate of the re-inhaled deposited virion dose. Section 6.2 explicitly concedes that 'whether' and 'under what conditions' self-aerosol reseeding plays a significant role remains unverified. Without at least an order-of-magnitude dose balance (e.g., virions produced per day in oropharyngeal fluids, fraction exhaled as aerosols, fraction re-deposited in the lung, vs. local replication rate in an established focus), the early dominance of aerosols is unsupported. The cited temporal alignment of oropharyngeal and pulmonary viral load peaks is also compatible with centrifugal spread from a single focus or hematogenous seeding, so it does not uniquely select the reseeding mechanism.","section":"Section 4.1.2"},{"comment":"The indirect evidence listed here is circular in structure. The model was constructed to match the clinical pattern of multifocal early CT lesions and later diffuse consolidation, and then Section 5.2.1 offers exactly those observations as support. This circularity weakens the evidential value of the cited consistency. The authors should distinguish model construction from independent validation, and propose a priori predictions that are not already embedded in the model. Examples could include quantitative spatial statistics of early lesion distribution compared with modeled aerosol deposition patterns, or the prediction that interventions reducing re-inhalation of self-aerosols (e.g., 24-hour filtration) should reduce pneumonia severity even when the infection rate is held constant. As it stands, the evidence is consistent with the model but does not provide a non-trivial test.","section":"Section 5.2.1"},{"comment":"The exudate-mediated transport phase assumes that inflammatory exudate forms a continuous, connected fluid network in the airways and alveoli, enabling rapid long-distance viral spread. This is a strong biophysical assumption that is asserted without anatomical or fluid-mechanical support. Exudate in alveoli is typically compartmentalized by alveolar septa and may be interspersed with air; airway 'rivers' may be interrupted by mucus plugs, surfactant, or non-flooded segments. The authors should justify the connectivity premise with evidence or with a simple model based on exudate volume relative to airway surface area and the expected filling patterns. Without such support, the exudate phase lacks a mechanistic basis beyond the metaphor of 'rivers.' Note that this point is independent of the T_threshold formalization in Section 4.3; even a well-defined probability P_exudate(t) would require a plausible physical mechanism for the connected fluid network.","section":"Section 4.2.2"},{"comment":"The model explicitly ignores the immune system, but the shift to exudate-mediated transport is defined by inflammation and fluid exudation, which are immune-driven. This is an internal tension that the paper acknowledges but does not resolve. At minimum, the model should include a phenomenological state variable for inflammation severity (e.g., capillary permeability or exudate volume) that evolves over time and is coupled to viral load, rather than treating the switch as a purely exogenous time threshold. The authors correctly note in Section 6.4.1 that future multi-compartment models should integrate immune parameters, but this acknowledgment does not substitute for a concrete, even simplified, representation of the inflammation dynamics that determines T_threshold. Without this link, the model cannot predict when the dominant mechanism shifts, only that it might shift.","section":"Section 6.4.1"}],"minor_comments":[{"comment":"The paragraph beginning 'However, it is noteworthy that for tiny aerosol particles' ends mid-sentence after '(typically', with no continuation. This editorial error must be fixed.","section":"Section 3.2.2"},{"comment":"The text refers to the ideal experiment design as '(4.2.2)', but the experiment is described in Section 5.2.2. The reference should be corrected.","section":"Section 5.2.3.1"},{"comment":"The phrase 'clustered in extremely small areas and distributed sparsely' is internally contradictory; please clarify whether the intended meaning is that pathogens are concentrated in a few small regions and absent elsewhere.","section":"Section 3.2.1"},{"comment":"'Dynamic equilibrium point' is a misleading term for a time at which the dominant mechanism switches; it is not an equilibrium of the system. Consider using 'transition point' or 'dominance switch' to avoid confusion.","section":"Section 4.3"},{"comment":"References [4] and [11] are preprints (Cold Spring Harbor Laboratory) and are not peer-reviewed; consider citing the published versions if they exist, or marking them as preprints.","section":"References"},{"comment":"The phrase 'for all, by all' with the parenthetical translation is unclear in English; consider rewording to convey the bidirectional-protection meaning more directly.","section":"Abstract"}],"recommendation":"major_revision","confidential_remarks":"The paper is a hypothesis paper in a field where quantitative models are expected. The main issue is that the central claim is not formally specified: T_threshold and the probabilities are placeholders, and the pivotal self-aerosol reseeding mechanism lacks any dose-balance estimate. These are fixable within the manuscript's scope by adding a simple quantitative framework (even with broad parameter ranges) and by distinguishing model construction from independent evidence. The paper also has several editorial errors (Section 3.2.2 cut-off, wrong section reference). The authors should be encouraged to revise rather than reject, because the proposed experiments and the emphasis on intrapulmonary physical transport are potentially valuable contributions, but the current form is more of a position paper than a testable model."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"What you should know: this is a hypothesis paper, clearly labeled as such, and it does something new. The two-phase idea—early multifocal seeding driven by aerosol deposition (including self-reseeding) and later diffuse spread driven by inflammatory exudate fluid transport—is not in the cited literature. The components are known, but the synthesis and the T_threshold switch are a legitimate conceptual contribution. The paper also earns credit for honesty: Section 6.2 explicitly flags the self-aerosol reseeding mechanism as the key unverified point and acknowledges the timing uncertainty of the threshold. It doesn't oversell what it has. The soft spots are real and, for a hypothesis paper, mostly acceptable. The central model is not formalized. T_threshold, P_aerosol(t), and P_exudate(t) are symbolic but never defined, so the claimed dynamic equilibrium has no operational meaning. The pivotal claim—that self-re-inhaled aerosols during the oropharyngeal viral load peak outpace local cell-to-cell spread—has no dose balance behind it. It is plausible, but the paper gives no order-of-magnitude estimate of deposited virions versus local replication. The mild circularity the reader noted is also there: Section 5.2.1 offers the same CT focal-to-diffuse pattern and viral load timing that motivated the model as supporting evidence. That's not disqualifying for a hypothesis, but it should be stated more carefully. The citation pattern is fine. The references are relevant and current, and the paper's use of them is qualitative but not abusive. The proposed experimental designs (prospective air-filtration cohort, retrospective historical cohort analysis) are sensible and appropriately hedged, though they are feasibility sketches more than protocols. Who is this for? Someone working on aerosol transmission or COVID-19 pathophysiology who wants a framework for thinking about intra-host physical transport. It is not a quantitative resource. It deserves a serious referee because the idea is testable in principle and the paper is coherent on its own terms, but the referee should push hard on the missing quantification of the reseeding step. I'd send it to review, not desk reject.","headline":"A genuinely new conceptual synthesis about two-phase intrapulmonary virus transport, but the load-bearing threshold is left symbolic and the key reseeding step is unquantified—worth a serious referee as a hypothesis paper, not as a validated result.","tokens_in":669,"tokens_out":742,"would_cite":false,"duration_ms":18557,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"The paper tries to establish that SARS-CoV-2 spreads within the lung by two successive physical carriers—inhaled and re-inhaled aerosols first, inflammatory exudate later—and that the switch between them explains why CT lesions evolve…","keywords":["SARS-CoV-2","aerosol transport","self-reseeding hypothesis","pulmonary exudate","lung lesion diffusion","CT imaging evolution","dynamic equilibrium point","respiratory infection model"],"falsifier":"If serial imaging or viral-genomic tracing in patients or animal models showed that all new lung foci appearing during the first five days after symptom onset arise contiguously from existing lesions, with no anatomically scattered independent foci, the self-aerosol reseeding arm would be contradicted; a second decisive check would be observing diffuse lesion fusion before measurable inflammatory exudate has formed.","tokens_in":13601,"feed_emoji":"🫁","tokens_out":9220,"duration_ms":87721,"temperature":0.7,"pith_summary":"COVID-19 pneumonia often begins as scattered, discrete lung opacities on CT and later merges into diffuse ground-glass shadows, and the paper asks what carries the virus between these sites. Its answer is a two-phase physical-transport model: tiny virus-laden aerosols seed infection at random deep-lung locations, including aerosols the patient exhales and re-inhales during an early high-viral-load window, and later, once inflammation produces fluid exudate, the infected exudate becomes the dominant vehicle that spreads virus through connected airways and alveoli. The two mechanisms meet at a dynamic equilibrium point $T_{\\mathrm{threshold}}$ where the dominant carrier switches. This matters because the model makes lung-disease progression partly a problem of ventilation and airflow inside the host, not only a problem of viral replication and immune damage, which opens concrete, low-cost interventions such as improving air exchange around an infected person and lowering oropharyngeal viral load.","feed_headline":"Aerosols seed COVID lung lesions; exudate spreads them","feed_subtitle":"Hypothesis: infection begins as scattered aerosol deposits, then inflammatory fluid carries virus across the lungs.","key_machinery":"The carrying mechanism is a dual-medium diffusion model with a switching threshold. The paper writes the time-dependent dominance of the two carriers as $P_{\\mathrm{aerosol}}(t)$ and $P_{\\mathrm{exudate}}(t)$, and defines $T_{\\mathrm{threshold}}$ as the time, inflammation severity, or infection extent at which exudate transport overtakes aerosol transport as the main route of intrapulmonary viral spread. This threshold does the explanatory work: it predicts that early CT lesions should appear as scattered foci while aerosol seeding rules, and that lesion fusion and diffuse consolidation should appear only after exudate formation connects the airway network as fluid-filled channels. The anatomical groundwork is the high-surface-area, deeply branching lung: tiny particles reach the periphery, while accumulated fluid later turns the same branching tree into a network of liquid passages.","core_discovery":"The central claim is that physical transport media, not only cell-to-cell replication and immune pathology, determine how SARS-CoV-2 colonizes and spreads within the lung. In the early phase, aerosol deposition—from external sources and from the host's own exhaled breath—produces multiple random infection foci, matching the multifocal pattern seen on early CT images; self-generated aerosols matter most in the window when oropharyngeal viral load is high but lung-specific immune defenses and exudate formation have not yet begun. In the later phase, inflammatory exudate filling the alveolar and airway spaces acts as a virus-carrying fluid that spreads across branching airways, turning discrete foci into diffuse lesions. The paper's precise object is the dynamic equilibrium point $T_{\\mathrm{threshold}}$: before it, aerosol-mediated transport dominates; after it, exudate-mediated transport dominates. The author presents this as a hypothesis, with indirect support from imaging, viral kinetics, and epidemiology, and with explicit acknowledgment that direct in-human validation is not currently feasible.","pith_inferences":["The two-medium logic transfers to other respiratory viruses, with a testable prediction: pathogens that replicate mainly in the upper airway and cause little exudative pneumonia should show a short aerosol-dominated phase and weak late diffuse spread.","A quantitative within-lung model could fit serial CT and viral-load time series: estimating $T_{\\mathrm{threshold}}$ from imaging, then comparing lesion-area growth slopes before and after, would give a numerical estimate of how much of early spread is aerosol reseeding versus contiguous cell-to-cell advance.","Because the paper simplifies immune clearance away, adding a simple clearance term would sharpen its prediction: self-aerosol reseeding should matter most in hosts whose adaptive immunity lags behind oropharyngeal viral load, which could explain individual variability in lesion patterns."],"forward_implications":["Lowering oropharyngeal viral load early—through gargling, nasal irrigation, or antiviral mouth rinses—should slow the appearance of new scattered lung foci if self-aerosol reseeding drives early expansion.","Improving ventilation and air filtration around an infected person should reduce both external seeding and re-inhalation of the patient's own aerosols, potentially changing disease severity and not just infection probability.","Serial CT should show a temporal ordering: scattered multifocal opacities first, diffuse ground-glass and consolidation only after exudate formation, with the timing varying by inflammation severity.","Once $T_{\\mathrm{threshold}}$ is passed, the value of further aerosol-reduction measures should drop, because the dominant transport mode has shifted to exudate flow."],"supporting_citations":[{"why":"Documents the CT evolution from focal to diffuse ground-glass opacities that the hypothesis is built to explain.","marker":"[1]"},{"why":"Provides the aerosol-deposition physics showing sub-5-micrometre particles reach the deep lung, the basis for aerosol seeding.","marker":"[2]"},{"why":"Provides clinical viral-load timing in the pulmonary compartment, used to date the later lung peak and the exudate-dominated phase.","marker":"[8]"},{"why":"Human challenge measurements of viral emissions ground the claim that infected hosts generate aerosol loads capable of reseeding themselves.","marker":"[9]"},{"why":"Shows exhaled SARS-CoV-2 aerosols are infectious enough to transmit within minutes, supporting both external and self-reseeding infectivity.","marker":"[13]"},{"why":"Hamster-model nasal irrigation data link lowering upper-airway viral load to reduced lung injury, supporting the self-aerosol arm.","marker":"[14]"},{"why":"Offers epidemiologic signal that gargling reduces hospitalization, consistent with oropharyngeal viral load driving lung progression through self-aerosols.","marker":"[15]"}],"fun_headline_variants":["Aerosols seed, exudate spreads: dual transport drives lung infection","Two-phase COVID lung spread: aerosols seed, exudate expands","How aerosols and exudate each drive COVID lung lesion growth","Aerosols start lung foci; exudate spreads them diffusely","Lung infection dynamics: aerosol seeding to exudate spread"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The load-bearing premise is that, in the first few days after symptoms begin, the host's own exhaled virus-laden aerosols deposit enough live virus into new lung regions to create new infection foci faster than other early mechanisms can spread or clear the virus.","fun_headline_variants_meta":{"raw":{"variants":["Aerosols seed, exudate spreads: dual transport drives lung infection","Two-phase COVID lung spread: aerosols seed, exudate expands","How aerosols and exudate each drive COVID lung lesion growth","Aerosols start lung foci; exudate spreads them diffusely","Lung infection dynamics: aerosol seeding to exudate spread"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.00078,"raw_usage":{"total_tokens":3497,"prompt_tokens":1043,"completion_tokens":2454,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":659,"completion_tokens_details":{"reasoning_tokens":2362}},"tokens_in":659,"tokens_out":2454,"duration_ms":18083,"temperature":1.0,"reasoning_tokens":2362,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-07T12:36:15.686667+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"If serial imaging or viral-genomic tracing in patients or animal models showed that all new lung foci appearing during the first five days after symptom onset arise contiguously from existing lesions, with no anatomically scattered independent foci, the self-aerosol reseeding arm would be contradicted; a second decisive check would be observing diffuse lesion fusion before measurable inflammatory exudate has formed.","supporting_citations":[{"cited_title":"dynamic equilibrium point","cited_arxiv_id":null,"evidence_quote":"Documents the CT evolution from focal to diffuse ground-glass opacities that the hypothesis is built to explain."},{"cited_title":"miasma theory,","cited_arxiv_id":null,"evidence_quote":"Provides the aerosol-deposition physics showing sub-5-micrometre particles reach the deep lung, the basis for aerosol seeding."},{"cited_title":"Saltwater Gargling May Help Avoid COVID Hospitalization","cited_arxiv_id":null,"evidence_quote":"Provides clinical viral-load timing in the pulmonary compartment, used to date the later lung peak and the exudate-dominated phase."}],"review_version":1}